India launches locally-made rare disease drugs, cost slashed by hundred-fold

The Union Health Ministry on Friday said that the four made-in-India drugs for rare diseases have been launched in the country. As the drugs for rare disease are being imported at expensive cost, these made-in-India drugs...

Sickle Cell Disease is multi-sectoral mission leveraging community mobilization, stakeholder collaboration: Dr. V K Paul

Sickle Cell Disease is a multi-sectoral mission leveraging community mobilization and stakeholder collaboration, said Dr. V K Paul, Member Health, Niti Aayog while addressing the Post Budget Webinar ‘Leaving No Citizen...